Research report on global diabetes device market

Published on February 6, 2014 at 8:32 AM · No Comments

Reportlinker.com announces that a new market research report is available in its catalogue: Trends and Opportunities in the Diabetes Care Market 

This report provides everything you need to know about the current market for diabetes care devices; from detailed analysis of the products, companies and developments influencing its growth to an in-depth manufacturer directory detailing company movements within the market and key financial data (where available)

The global market for diabetes devices was estimated to be worth US$ 12 2 billion in 2012 And although this market was in decline due to intense competition and low reimbursement levels, as well as being traditionally dominated by 6 major manufacturers, good opportunities are growing more apparent for companies with unique diabetes devices or that compete in yet to be established markets

In geographical terms, the US market dominates this sector, with Europe and other developed markets close behind However, while these regions are experiencing pricing pressures and slower than usual sales volumes as a result of the economic downturn and government reductions in healthcare spending, there has been strong demand for SMBG (Self-monitoring blood glucose) and manual insulin delivery products in emerging and developing nations

This new report from Espicom provides a complete and comprehensive review of the current diabetes device market, highlighting and analysing the market leaders, competing products and new developments across a wide range of technology areas Furthermore, this report also acts as a diabetes device manufacturer directory detailing each company's recent key events in the diabetes sector and providing granular financial data (where available)

What this report contains:

Executive Summary
Market overview covering the global diabetes market, the competitive environment and the growth drivers, restraints and future opportunities
Market dynamics, detailed breakdown of key leading products, competing products and products in development for Diabetes Monitoring Products and Insulin Delivery Products
Current products and products in development within Combined CGM-Insulin Pump Systems technologies
Current research and development for Artificial Pancreas Technologies
Diabetes device company directory and company profiles for market-leading companies, detailing recent key events and important financial data

The Diabetes report is the foolproof business resource for any industry executive that needs to fully understand the current players and future prospects within the global diabetes market The need for hard facts and statistics to back up everyday business decisions is essential and it is this report that can provide you with the answers

Contents
EXECUTIVE SUMMARY1
MARKET OVERVIEW2
BACKGROUND2
Diagnosis and Management of Diabetes2
Insulin-Dependent Diabetes Patients3
Current Trends in Diabetes Care4
THE GLOBAL BURDEN OF DIABETES4
Diabetes Prevalence5
Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group Study 6
Mortality 7
Diabetes Complications 7
The Cost of Diabetes8
THE DIABETES DEVICE MARKET9
Product Segments10
Current Market Trends 13
Regional Perspective 15
COMPETITIVE ENVIRONMENT17
New Market Entrants20
Market Withdrawals20
Rounding Out Product Portfolios21
Market Consolidation22
GROWTH DRIVERS, RESTRAINTS AND FUTURE OPPORTUNITIES22
Regulatory and Reimbursement Environment23
Connectivity and Data Integration25
The Role of Telemonitoring in Diabetes Care25
Emerging Technologies27
New-Generation Insulin Delivery Devices27

Development of a Closed-Loop System28
Rival Technologies28
Bariatric Surgery for Type 2 Diabetes29
MARKET EXPECTATIONS30
DIABETES MONITORING PRODUCTS32
MARKET DYNAMICS34
MANUAL SELF-MONITORING BLOOD GLUCOSE PRODUCTS36
Current Market Environment37
Regional Markets and Reimbursement39
Accuracy Standards40
GDH-PQQ Test Strips41
New Product Developments42
SMBG for Type 2 Diabetes Patients42
Market Forecast43
Competitive Environment45
Market-Leading Self-Testing Blood Glucose Meters47
Abbott's Blood Glucose Monitors 47
FreeStyle Blood Glucose Monitors and Test Strips47
Arkray's Glucocard Products48
Bayer's Blood Glucose Monitoring Systems50
Contour Next Link50
Contour Next and Contour Next USB51
Contour USB51
Contour, Contour TS, Contour Link and Breeze 251

LifeScan Products52

Consumer Blood Glucose Monitoring Products52
Nipro Diagnostics' TRUE Products55
TRUE2go and TRUEresult55
Roche Diabetes Care's Products 56
Blood Glucose Monitoring Products56
Accu-Chek Aviva Expert 57
Accu-Chek FastClix Lancing Device57
Other Market Participants57
Product Highlights59
ACON Laboratories' On Call Products59
Bionime's BGMs60
BodyTel Europe's GlucoTel 60
Cardiocom's Diabetes Management System 60
Decision Diagnostics'/Shasta Technologies' Genstrip Blood Glucose Test Strip60
Entra Health Systems' MyGlucoHealth Network 61
IDEAL LIFE Gluco-Manager62
Infopia's Blood Glucose Products62
Max Medical's Minipro Self-Monitoring Blood Glucose System62
Medisana's GlucoDock63
Menarini's GlucoMen LX Plus/Glucofix Mio Plus63
PositiveID/Smart Glucose Meter Corporation's iglucose63
Sanofi's BGStar and iBGStar63
Telcare's Telcare BGM64
Ypsomed's mylife Unio65
Products in Development65
Intuity Medical's POGO Blood Glucose Monitoring System 65

National Diagnostic Products' BETACHEK C50 Cassette System 65
CONTINUOUS GLUCOSE MONITORING 66
The Benefits of CGM 66
Barriers to Adoption66
The Cost of CGM67
Clinical Trial Results - Highlighting Benefits and Drawbacks67
The TD1 Exchange: User Experiences of CGM68
CGM Market Trends and Opportunities69
Regional Adoption Rates, Regulatory and Reimbursement Environment 70
United States71
International Market 71
Future Prospects 72
Competitive Environment74
Currently-Available Products76
Medtronic's Guardian REAL-Time CGM System 76
Medtronic's Enlite CGM Sensor 77
DexCom's CGMs 77
SEVEN PLUS CGM System77
DexCom G4 PLATINUM CGM 78
GlucoClear78
Abbott's FreeStyle Navigator II 79
A Menarini Diagnostics' GlucoDay S 79
Products in Development79
DexCom's Research and Development 79
DexCom Share System80
Paediatric Use CGM in the US80
Alliance with the Juvenile Diabetes Research Foundation 80
Roche's CGM System81

New-Generation Implantable CGM Sensors81
BioTex' Implantable CGM81
EyeSense's FiberSense System81
GlySens' ICGM82
PositiveID & RECEPTORS' GlucoChip82
Senseonics' CGM System83
Minimally-Invasive CGM in Development 84
Echo Therapeutics' Symphony tCGM System84
North Carolina State University, Sandia National Laboratories and University of California, San Diego's Microneedle Sensors 86
Sysmex' Minimally-Invasive ISF Extraction Technology (MIET)87
NON-INVASIVE GLUCOSE MONITORING88
Competitive Environment88
AIMEDICS' HypoMon 89
Biosign Technologies' UFIT TEN-20 Non-Invasive Blood Pressure and Glucose Meter 90
Biovotion's Multisensor Glucose Monitoring System90
Integrity Applications' GlucoTrack DF-F91
Optical Technologies92
EyeSense's Optical Sensor92
Freedom Meditech's I-SugarX Glucose Monitoring System92
Grove Instruments' Grove Glucometer93
Lein Applied Diagnostics93

LighTouch Medical's Non-Invasive Glucose Monitor 94
Massachusetts Institute of Technology's Raman Spectroscopy System 95
OrSense's NBM-200G Non-Invasive Blood Glucose Meter 95
St Louis Medical Devices Near-Infrared Light-Based System 95
Smart Tattoos 96
BioTex' Smart Tattoo96
Charles Stark Draper Laboratory96
Massachusetts Institute of Technology's Smart Tattoo96
University of Strathclyde and King's College London96
Tear Fluid Glucose Sensors97
Mayo Clinic, Arizona State University and BioAccel 97
University of Washington and Microsoft Research 97
The University of Western Ontario's Glucose Monitoring Contact Lenses 98
Breath-Based Glucose Monitoring 98
PositiveID's EasyChek 98
Xhale's Breath-Based Glucose Monitor 99
Brown University and Saliva-Based Glucose Testing 99
INSULIN DELIVERY PRODUCTS 100
ADDRESSABLE PATIENT POPULATION 101
MARKET TRENDS 102

Competitive Environment104
FUTURE MARKET PROSPECTS104
MANUAL INSULIN INJECTION PRODUCTS106
Insulin Pens107
Competitive and Market Environment 108
Currently-Available Products 109
Biocon's INSUPen109
Eli Lilly's HumaPen, Memoir and KwikPen Products 109
Owen Mumford's Autopen 110
Novo Nordisk's Products 110
Sanofi's AllSTAR, SoloSTAR and ClikSTAR111
Ypsomed Delivery Systems111
Ypsomed and Tonghua Dongbao Pharmaceutical's Sulin and Gansulin Pens 112
Needles and Syringes112
v

Pen Needles113
BD Diabetes Care Products113
INSULIN PUMPS114
The TD1 Exchange: User Experiences of Insulin Pumps115
Current Market Trends 116
Regional Perspective117
User Adoption Rates 118
Cost and Reimbursement119
Regulatory Environment - FDA Infusion Pump Improvement Initiative 119
The Potential for Cyber Attacks 120
Competitive Environment121
Market Outlook 122
Currently-Available Insulin Pumps 124
Animas Insulin Pumps124
Animas Vibe 124
OneTouch Ping Glucose Management System 124
Asante Solutions' Asante Snap Insulin Pump124
Medtronic's MiniMed Paradigm Revel Insulin Pump and Infusion Sets 125
Medtronic Paradigm Insulin Reservoir Recall125
FDA Warning Letter 126
Sooil Development's Diabecare Insulin Pumps127
Roche Insulin Pumps127
Accu-Chek Combo BGM and Pump System128
Accu-Chek Spirit 128
Accu-Check D-TRONplus128
Tandem Diabetes Care's t:slim Insulin Delivery System 128
Insulin Delivery Patch Pumps 129
CeQur's PaQ Insulin Delivery Device 129

Cellnovo's Mobile Diabetes Management System129
Insulet's OmniPod Insulin Management System130
Valeritas' V-Go 132
Products in Development133
Becton Dickinson-JDRF Micro-Needle Technology 133
Debiotech's JewelPUMP133
Insulet's OmniPod for Humulin R U-500 Insulin 134
Roche's R&D Pipeline 134
Accu-Chek Insight and NovoRapid PumpCart 135
Johnson & Johnson's Calibra Wearable Insulin Patch135
Tandem Diabetes Care's Pipeline135
t:flex Insulin Pump 135
t:sensor Insulin Pump and CGM System136
t:sport Insulin Delivery System 136
t:dual Infusion System 136
Ypsomed's New Insulin Pump 136
ALTERNATIVE INSULIN DELIVERY DEVICES 137
Generex Biotechnology's Oral-lyn137
Insulin Inhalers138
Development Considerations 138
MannKind's AFREZZA 139
Dance Pharmaceuticals' Adagio 141
INTEGRATED CGM-INSULIN PUMP SYSTEMS143
CURRENTLY-AVAILABLE PRODUCTS 143
Medtronic's Integrated Diabetes Management Products143
Clinical Trials 144
STAR Studies 144
REAL Trend Study 144

Animas Vibe145
PRODUCTS IN DEVELOPMENT 145
Insulet's CGM-Enabled OmniPod145
ARTIFICIAL PANCREAS TECHNOLOGY 146
SEMI-CLOSED-LOOP SYSTEMS 147
Medtronic's Low Glucose Suspend/Threshold Suspend Automation Technology 147
Paradigm Veo with Low Glucose Suspend147
MiniMed 530G System147
ASPIRE Study 148
ASPIRE In-Home148
RESEARCH & DEVELOPMENT 148
FDA Artificial Pancreas Development Guidelines 148
Key Closed-Loop Development Projects149
The Juvenile Diabetes Research Foundation's Artificial Pancreas Project 150
Real-World Artificial Pancreas Study150
University of Cambridge Studies 151
UC Santa Barbara & Sansum Diabetes Research Institute 152
Massachusetts General Hospital and Boston University 152
JDRF-Helmsley Charitable Trust Sensor Initiative 153
Collaboration with BD 153

Collaboration with Medtronic 153
Collaboration with Tandem Diabetes Care154
Collaboration with DexCom154
Collaboration with Animas154
Medtronic's Closed-Loop Diabetes Management System 155
Overnight Closed Loop Studies 155
Mayo Clinic 156
UC Santa Barbara, Sansum Diabetes Research Institute, Mayo Clinic, Universities of Virginia & Padova 156
AP@home Project 156
MD-Logic Artificial Pancreas System 157
DREAM Project157
Rensselaer Polytechnic Institute 158
Clinical Studies 159
DIABETES DEVICE MANUFACTURERS 160
DIABETES DEVICE COMPANY DIRECTORY160
Abbott Laboratories 168
FreeStyle Navigator II Continuous Glucose Monitoring System 169
Blood Glucose Monitors 169
FreeStyle Blood Glucose Monitors and Test Strips169
Precision Xtra/Optium Xceed System 170
CoPilot Health Management System 170
Precision XceedPro and PrecisionWeb Professional Use Products 171

Alliance with Insulet171
Litigation 171
DexCom 171
Financial Performance 172
Latest Results172
Arkray174
Blood Glucose Self-Testing174
Glucocard Meters 174
Assure Products 175
Current Alliances and Contracts176
MyCareTeam 176
A Menarini Diagnostics 176
vii

Bayer177
Blood Glucose Monitoring Systems 177
Contour Next Link177
Contour Next and Contour Next USB 178
Contour USB 179
Contour, Contour TS, Contour Link and Breeze 2 179
Alliance with Medtronic 180
Financial Performance 180
Becton, Dickinson and Company181

BD Diabetes Care Products 181
BD Ultra-Fine Nano 4mm Pen Needle with EasyFlow Technology 182
BD Ultra-Fine Nano Pen Needle182
AutoShield Duo Pen Needle182
Collaboration with the JDRF 182
Litigation with Insulet 183
Financial Performance 183
DexCom185
SEVEN PLUS CGM System 186
DexCom G4 PLATINUM CGM 187
GlucoClear 187
Research and Development 187
DexCom Share System188
Paediatric Use CGM in the US188
SweetSpot Diabetes Care Acquisition 188
Current Alliances 189
Juvenile Diabetes Research Foundation 189
Tandem Diabetes Care 189
Edwards LifeSciences189
Animas 190
Litigation with Abbott 190
Financial Performance191
Latest Results and Outlook 191
Insulet193
OmniPod Insulin Management System 194
Research and Development 194
Current Alliances 195

Eli Lilly and Company195
LifeScan195
Abbott 195
Ypsomed 195
GlaxoSmithKline196
Flextronics International 196
Acquisition of Neighborhood Diabetes 196
Litigation 196
Medtronic 196
Rydex Technologies 197
Becton, Dickinson and Company 197
Financial Performance 197
Latest Results and Outlook198
Johnson & Johnson199
Animas Operations200
Animas Products200
Current Alliances201
Litigation with Medtronic 202
Calibra Medical Operations 202
©Espicom B December 2013 usiness Intelligence ix
Trends and Opportunities in the Diabetes Care Market SectionName
LifeScan Operations 202
Consumer Blood Glucose Monitoring Products203
Current Alliances206
Litigation 207
Financial Performance 207
Medtronic 209
Enlite CGM Sensor 210
Integrated Diabetes Management Products 210
Paradigm Veo with Low Glucose Suspend 210
MiniMed 530G System 211
MiniMed Paradigm REAL-Time Revel 212
MiniMed Paradigm Revel Insulin Pump and Infusion Sets212
Medtronic Paradigm Insulin Reservoir Recall 213
FDA Warning Letter 213
Guardian REAL-Time CGM System 214

Professional Use CGM Products215
Sentrino CGM System 215
iPro 2 Professional 215
CareLink Software215
Bayer Contour Link and Contour Next Link Blood Glucose Meters 216
Research and Development216
Closed-Loop Diabetes Management System 216
Key Alliances217
National Institute of Hospital Administration, China 217
Bayer 218
Litigation 218
Insulet 218
Animas 218
Financial Performance218
Nipro Diagnostics 220
Blood Glucose Monitoring Products 221
Blood Glucose Monitors 221
TRUE2go and TRUEresult221
TRUEread222
TRUEbalance222
TRUEtrack222
TRUEmanager Diabetes Management Software 222
Alliance with NextGen Healthcare Information Systems222
Roche Diabetes Care 224
Diabetes Care Products225
Blood Glucose Monitoring Products225
Accu-Chek Aviva Expert 226
Accu-Chek FastClix Lancing Device226
Accu-Chek Combo BGM and Pump System 226
Insulin Pumps 226
Accu-Chek Spirit 227

Accu-Check D-TRONplus227
Data Management Tools 227
Research & Development 227
Accu-Chek Insight and NovoRapid PumpCart227
SOLO Micropump227
Current Alliances228
Novo Nordisk228
InterComponentWare228
Litigation with LifeScan228
x ntelligence December 2013

Financial Performance228
Latest Results230
Ypsomed231
mylife Diabetes Care Products 232
mylife Unio BGM232
mylife Pura BGM233
Ypsomed Delivery Systems 233
Acquisition of ICU Medical's Orbit Infusion Set Business 233
In Development: New Insulin Pump 233
Current Alliances234

Tonghua Dongbao Pharmaceutical Co Ltd234
Lifescan234
Insulution AB234
B Braun234
Distribution Agreements234
Insulet235
Bionime235
Financial Performance 235
APPENDICES 238
LIST OF ABBREVIATIONS238
REPORT METHODOLOGY239
List of Tables
Diabetes Prevalence for the Top 10 Countries, 2011-2030 (million)6
Global Diabetes Market by Product Type, 2006-2012 (US$ million)14
Global Diabetes Market Growth Rates by Product Type, 2006-2011 (%)15
Key Companies' Diabetes Care Sales, 2005-2012 (US$ million)18
Non-US Companies' Diabetes Sales in Reported Currency, 2006-2012 (million)19
Leading Companies' International Diabetes Care Sales, 2006-2012 (US$ million)19
Key Companies' US Diabetes Care Sales, 2006-2012 (US$ million)19
Key Companies: Market Presence & Position by Product Area, 201221
Key Companies: Current & Future Potential Market Presence by Product Area22
Global Diabetes Market Forecast by Product Type, 2012-2018E (US$ million)31
Global Diabetes Market Forecast Growth Rates by Product, 2012-2018E (%)31
Overview: Glucose Monitoring Products33
Public Companies' Glucose Monitoring Sales, 2006-2012 (US$ million)35
SMBG Market by Major Geographic Region, 2011-2012 (US$ million) 40
Summary: SMBG Growth Drivers, Restraints & Opportunities 44
Key Companies' SMBG Sales, 2006-2012 (US$ million)45
Competing Self-Testing Blood Glucose Monitoring Products57
Summary: CGM Benefits, Challenges & Opportunities74

Companies' CGM Sales, 2006-2012 (US$ million)75
Insulin Delivery Market by Product Type 2005-2012 (US$ million)102
Key Companies' Insulin Delivery Sales, 2006-2012 (US$ million) 104
Summary: Insulin Delivery Market Growth Drivers, Restraints & Opportunities105
Insulin Delivery Market Forecast by Product Type 2012-2018E (US$ million)105
Insulin Pump Market: Growth Drivers, Restraints & Opportunities115
Key Companies' Insulin Pump Sales, 2006-2012 (US$ million)122
Recent Key Events168
Abbott Diabetes Care Sales by Region, 2007-2012 (US$ million)172
Recent Key Events174
Recent Key Events177
Bayer Diabetes Care Revenue, 2008-2012 (EUR million) 180
Recent Key Events181
©Espicom B December 2013 usiness Intelligence xi
Trends and Opportunities in the Diabetes Care Market SectionName
List of Charts
Fig1: Diabetes Prevalence by Geographic Region, 2011-20306
Fig2: Diabetes Device Market by Major Product Category, 2012 11
Fig3: Percentage of US Diabetes Patients by Treatment Type, 2007-2009 11
Fig4: Diabetes Device Market by Product Type, 2012 13
Fig5: Global Diabetes Device Market, 2005-2012 (US$ billion) 13
Fig6: Global Diabetes Market By Product Type, 2006-2012 (US$ billion) 15
Fig7: Global Diabetes Device Market by Region, 201216
Fig8: US Market by Product Type, 201216
Fig9: International Market by Product Type, 2012 17
Fig10: Diabetes Device Market Share by Company, 201218
Fig11: Diabetes Device Market by Product, 2018E 31
Fig12: Global Glucose Monitoring Market, 2005-2012 (US$ billion)34
Fig13: Global Glucose Monitoring Market Growth, 2005-2012 (%)35
Fig14: Glucose Monitoring Market by Product Type, 201235
Fig15: Glucose Monitoring Market Share by Company, 201236
Fig16: Global SMBG Market, 2005-2012 (US$ million)38
Fig17: Global SMBG Market Growth Rates, 2005-2012 (%)38
Fig18: SMBG Market by Product Type, 201239

Fig19: SMBG Market by Region, 201240
Fig20: Global SMBG Market, 2012-2018E (US$ billion)44
Fig21: Global SMBG Market Growth Rates, 2012-2018E (%)44
Fig22: SMBG Market Share by Company, 201246
Fig23: United States SMBG Market Share by Company, 201246
Fig24: SMBG International Market Share by Company, 201246
Fig25: Global CGM Market, 2006-2012 (US$ million)69
Fig26: Percentage of CGM Sales Volumes by Hardware & Consumables, 201270
Fig27: CGM Market by Region, 201270
Fig28: Global CGM Market Forecast, 2012-2018E (US$ million)73
Fig29: Global CGM Market Growth Rates, 2012-2018E (%)73
Fig30: Global CGM Market Shares by Company, 201275
Fig31: US CGM Market Shares by Company, 201275
Fig32: International CGM Market Shares by Company, 201276
Fig33: Percentage of US Diabetes Patients by Treatment Type, 2007-2009102
Fig34: Global Insulin Delivery Market, 2007-2012 (US$ billion) 103
Fig35: Global Insulin Delivery Market Growth Rates, 2006-2012 (%) 103
Fig36: Percentage of Insulin Delivery Market by Product Type, 2012103
Fig37: Global Insulin Delivery Market Estimated Growth Rates, 2012-2018E (%) 105
BD Diabetes Care Sales by Region, 2008-2012 (US$ million)183
Recent Key Events186
DexCom - Operating Results, 2008-2012 (US$ million)191
Recent Key Events193
Insulet - Operating Results, 2008-2012 (US$ thousands)198
Recent Key Events 200

J&J Diabetes Care Revenue, 2007-2012 (US$ million) 208
Recent Key Events 209
Medtronic - Diabetes Sales by Region, Fiscal 2008-2013 (US$ million)219
Recent Key Events 220
Recent Key Events225
Roche Diabetes Care Sales by Region, 2011-2012 (SFr million)229
Recent Key Events231
Ypsomed - Operating Results, Y/E 31st March 2011-2013 (SFr millions)236
Ypsomed - Results by Business Segment, Y/E 31st March 2011-2013 (SFr millions)236
Ypsomed - Revenue by Geographic Region, Y/E 31st March 2011-2013 (SFr millions)236
xi

Fig38: Estimated Insulin Delivery Market by Product Type, 2018E106
Fig39: Percentage of Novo Nordisk's Insulin Sold in Pens by Region, 2011-2012107
Fig40: Manual Insulin Delivery Market by Geographic Region, 2012107
Fig41: Global Insulin Pen Market: Disposable vs Reusable Pens, 2012108
Fig42: Global Insulin Pump Market, 2005-2012 (US$ million) 116
Fig43: Global Insulin Pump Market Growth Rates, 2006-2012 (%) 117
Fig44: Insulin Pump Market by Product, 2012117
Fig45: Insulin Pump Market by Region, 2012 118
Fig46: Insulin Pump Adoption Rates for Type 1 Diabetes Patients by Key Country, 2010 (%) 119
Fig47: Insulin Pump Market Shares, 2012 122
Fig48: Global Insulin Pump Market Forecast, 2012-2018E (US$ million) 123
Fig49: Global Insulin Pump Market Estimated Growth Rates, 2012-2018E (%) 123
Fig50: Percentage of Abbott Diabetes Care Revenue by Region, 2012 172
Fig51: Percentage of BD Diabetes Care's Revenue by Region, 2012184
Fig52: J&J Diabetes Care Sales by Region, 2012208
Fig53: J&J Diabetes Care Sales, 2004-2012 (US$ million)208
Fig54: Medtronic Diabetes Revenue, Fiscal 2005-2013 (US$ million) 219
Fig55: Medtronic Diabetes Revenue by Region, Fiscal 2013 219
Fig56: Roche Diabetes Care - Revenue by Product Line, 2012229
Fig57: Roche Diabetes Care - Revenue by Region, 2012229
Fig58: Ypsomed - Revenue by Business Segment, Fiscal 2012/13237
Fig59: Ypsomed - Revenue by Geographic Location, Fiscal 2012/13 237

Source:

Reportlinker

Read in | English | Français | Português | Italiano | 日本語 | 한국어 | Nederlands | Русский | Svenska | Polski
Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Using a nanotech microchip to diagnose type 1 diabetes: an interview with Dr. Brian Feldman, Stanford School of Medicine